The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Inadequately low serum levels of steroid hormones in relation to interleukin‐6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis
Abstract
Objective: To compare levels of steroid hormones in relation to cytokines and to study levels of cortisol or dehydroepiandrosterone (DHEA) in relation to other adrenal hormones in untreated patients with early rheumatoid arthritis (RA) and reactive arthritis (ReA) compared with healthy controls. Methods: In a retrospective study with 34 RA patients, 46 ReA patients, and 112 healthy subjects, we measured serum levels of interleukin‐6 (IL‐6), tumor necrosis factor (TNF), adrenocorticotropic hormone (ACTH), cortisol, 17‐hydroxyprogesterone (17‐OH‐progesterone), androstenedione (ASD), DHEA, and DHEA sulfate (DHEAS). Results: RA patients had higher serum levels of IL‐6, TNF, cortisol, and DHEA compared with ReA patients and healthy subjects, but no difference was noticed with respect to ACTH and DHEAS. However, in RA and ReA patients compared with healthy subjects, levels of ACTH, cortisol, ASD, DHEAS, and 17‐OH‐progesterone were markedly lower in relation to levels of IL‐6 and TNF. Furthermore, the number of swollen joints correlated inversely with the ratio of serum cortisol to serum IL‐6 in RA (R Rank = −0.582, P = 0.001) and, to a lesser extent, in ReA (R Rank = −0.417, P = 0.011). In RA patients, the mean grip strength of both hands was positively correlated with the ratio of serum cortisol to serum IL‐6 (R Rank = 0.472, P = 0.010). Furthermore, in these untreated patients with RA and ReA, there was a relative decrease in the secretion of 17‐OH‐progesterone, ASD, and DHEAS in relation to DHEA and cortisol. This indicates a relative predominance of the nonsulfated DHEA and cortisol in relation to all other measured adrenal steroid hormones in the early stages of these inflammatory diseases. Conclusion: This study indicates that levels of ACTH and cortisol are relatively low in relation to levels of IL‐6 and TNF in untreated patients with early RA and ReA compared with healthy subjects. The study further demonstrates that there is a relative increase of DHEA and cortisol in relation to other adrenal hormones, such as DHEAS. This study emphasizes that adrenal steroid secretion is inadequately low in relation to inflammation. Although changes in hormone levels are similar in RA and ReA, alteration of steroidogenesis is more pronounced in RA patients than in ReA patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adrenocortical dysfunction, termed also as ‘relative’ or ‘functional’ adrenal insufficiency, has been described in patients with rheumatoid arthritis (RA) without any prior risk of, or evidence of, overt adrenal insufficiency.1–8”
From Diurnal production of cortisol and prediction of treatment response in rheumatoid arthritis: a 6-month, real-life prospective cohort study (2024) · cites this paper as [7]
In the citing paper
“In chronic inflammatory diseases such as systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA) the HPA axis alters markedly : (a) secretion of adrenocorticotropic hormone (ACTH) relative to circulating cytokines is inadequate 7 ; (b) patients have inappropriately low sponta- neous and stimulated cortisol secretion in relation to inflammation”
In the citing paper
“Indeed, in aging and in chronic inflammatory diseases, both the SNS and the HPA axis are chronically activated [41, 46–48].”
From Evolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiology (2012) · cites this paper as [48]
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,753
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,742
Graphic representation of pain
Scott, J., & Huskisson, E. C. (1976) · Pain · doi:10.1016/0304-3959(76)90113-5 · Cited by 2,706
Admission criteria for immunogerontological studies in man: The senieur protocol
Ligthart, G. J., Corberand, J. X., Fournier, C., Galanaud, P., Hijmans, W., Kennes, B., Müller-Hermelink, H. K., & Steinmann, G. G. (1984) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(84)90152-0 · Cited by 754
Straub, R. H., Konecná, L., Hrach, S., Rothe, G., Kreutz, M. P., Schölmerich, J., Falk, W., & Lang, B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4876 · Cited by 351
Self-citationJÄÄTTELÄ, M., ILVESMÄKI, V., VOUTILAINEN, R., STENMAN, U.-H., & SAKSELA, E. (1991) · Endocrinology · doi:10.1210/endo-128-1-623 · Cited by 243
Crofford, L. J. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.4.1279 · Cited by 242
Tsigos, C., Papanicolaou, D. A., Defensor, R., Mitsiadis, C. S., Kyrou, I., & Chrousos, G. P. (2008) · Neuroendocrinology · doi:10.1159/000127219 · Cited by 223
Päth, G., Bornstein, S. R., Ehrhart‐Bornstein, M., & Scherbaum, W. A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4072 · Cited by 200
Cutolo, M., Balleari, E., Giusti, M., Monachesi, M., & Accardo, S. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780311015 · Cited by 144
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1210/jc.74.2.362 · DOI
Cited by
Sorted by citations
Karlson, E. W., Mandl, L. A., Hankinson, S. E., & Grodstein, F. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20621 · Cited by 400
Energy regulation and neuroendocrine–immune control in chronic inflammatory diseases
Straub, R. H., Cutolo, M., Buttgereit, F., & Pongratz, G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02218.x · Cited by 382
Self-citationMeasurement and meaning of salivary cortisol: A focus on health and disease in children
Jessop, D. S., & Turner‐Cobb, J. M. (2008) · Stress · doi:10.1080/10253890701365527 · Cited by 284
Neural immune pathways and their connection to inflammatory diseases.
Eskandari, F., Webster, J. I., & Sternberg, E. M. (2003) · Arthritis Research · doi:10.1186/ar1002 · Cited by 201
Etiology and Risk Factors for Rheumatoid Arthritis: A State-of-the-Art Review
Romão, V. C., & Fonseca, J. E. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.689698 · Cited by 228
Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)
Buttgereit, F., Mehta, D., Kirwan, J., Szechiński, J., Boers, M., Alten, R., Supronik, J., Szombati, I., Romer, U., Witte, S., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201067 · Cited by 192
Davis, M. C., Zautra, A. J., Younger, J., Motivala, S. J., Attrep, J., & Irwin, M. R. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.06.013 · Cited by 177
Lerman, I. R., Hauger, R. L., Sorkin, L. S., Proudfoot, J. A., Davis, B. A., Huang, A., Lam, K. J. K., Simon, B. J., & Baker, D. G. (2016) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12398 · Cited by 173
Koopman, F. A., Stoof, S. P., Straub, R. H., van Maanen, M. A., Vervoordeldonk, M. J., & Tak, P. P. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00065 · Cited by 159
Self-citationExtra-adrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders
Slominski, R. M., Tuckey, R. C., Manna, P. R., Jetten, A. M., Postlethwaite, A., Raman, C., & Slominski, A. T. (2020) · Genes & Immunity · doi:10.1038/s41435-020-0096-6 · Cited by 155
Anti‐interleukin‐6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases
Tanaka, T., Narazaki, M., & Kishimoto, T. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.023 · Cited by 148
Fatigue in inflammatory rheumatic diseases: current knowledge and areas for future research
Davies, K., Dures, E. K., & Ng, W. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00692-1 · Cited by 147
Cutolo, M., SERIOLO, B., Craviotto, C., Pizzorni, C., & Sulli, A. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.7.593 · Cited by 136
Brain-immune interactions and disease susceptibility
Marques-Deak, A., Cizza, G., & Sternberg, E. M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001643 · Cited by 134
Karlson, E. W., Chibnik, L. B., Tworoger, S. S., Lee, I.-M. M., Buring, J. E., Shadick, N. A., Manson, J. E., & Costenbader, K. H. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24350 · Cited by 130
Morris, G., Anderson, G., & Maes, M. H. J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0170-2 · Cited by 127
Local and systemic glucocorticoid metabolism in inflammatory arthritis
Hardy, R., Rabbitt, E. H., Filer, A. D., Emery, P., Hewison, M., Stewart, P. M., Gittoes, N. J. L., Buckley, C. D., Raza, K., & Cooper, M. S. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.090662 · Cited by 118
Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms
Cutolo, M., Villaggio, B., Otsa, K., Aakre, O., Sulli, A., & SERIOLO, B. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.04.019 · Cited by 118
Härle, P., Straub, R. H., Wiest, R., Mayer, A., Schölmerich, J., Atzeni, F., Carrabba, M., Cutolo, M., & Sarzi-Puttini, P. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.038059 · Cited by 114
Self-citationEvolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiology
Straub, R. H. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0861-8 · Cited by 105
Self-citationStraub, R. H. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4688 · Cited by 100
Self-citationAlten, R., DÖRING, G., Cutolo, M., Gromnica‐Ihle, E., WITTE, S., Straub, R. H., & Buttgereit, F. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100051 · Cited by 93
Self-citationTherapeutic Monoclonal Antibody Concentration Monitoring: Free or Total?
Kuang, B., King, L., & Wang, H. F. (2010) · Bioanalysis · doi:10.4155/bio.10.64 · Cited by 93
Cutolo, M., Maestroni, G. J. M., Otsa, K., Aakre, O., Villaggio, B., Capellino, S., Montagna, P., Fazzuoli, L., Veldi, T., Peets, T., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.023416 · Cited by 91
Straub, R., Bijlsma, J., Masi, A., & Cutolo, M. (2013) · Seminars in Arthritis & Rheumatism · doi:10.1016/j.semarthrit.2013.04.008 · Cited by 83
Self-citationStraub, R. H., & Besedovsky, H. O. (2003) · The FASEB Journal · doi:10.1096/fj.03-0433hyp · Cited by 85
Self-citationAutoimmune diseases and reproductive aging
Bove, R. M. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.02.010 · Cited by 84
Mader, R., Lavi, I., & Luboshitzky, R. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20884 · Cited by 83
Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics
Gill, K. L., Machavaram, K. K., Rose, R. H., & Chetty, M. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0361-4 · Cited by 82
Straub, R. H., GÜNZLER, C., Miller, L. E., Cutolo, M., Schölmerich, J., & Schill, S. (2002) · The FASEB Journal · doi:10.1096/fj.02-0085com · Cited by 81
Self-citationCannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis
Lowin, T., & Straub, R. H. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0743-x · Cited by 82
Self-citationCircadian Rhythms and Arthritis
Cutolo, M., & Masi, A. T. (2005) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.09.005 · Cited by 82
Janele, D., Lang, T., Capellino, S., Cutolo, M., da Silva, J. A. P., & Straub, R. H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1351.015 · Cited by 77
Self-citationHypothalamic‐Pituitary‐Adrenocortical and Gonadal Functions in Rheumatoid Arthritis
Cutolo, M., Sulli, A., Pizzorni, C., Craviotto, C., & Straub, R. H. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03142.x · Cited by 75
Self-citationTanaka, T., Kuwahara, Y., Shima, Y., Hirano, T., Kawai, M., Ogawa, M., Arimitsu, J., Hagihara, K., Narazaki, M., Ogata, A., et al. (2009) · Arthritis Care & Research · doi:10.1002/art.24899 · Cited by 74
Capellino, S., Straub, R. H., & Cutolo, M. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12398 · Cited by 74
Self-citationTang, M. W., García, S., Gerlag, D. M., Tak, P. P., & Reedquist, K. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00720 · Cited by 74
Circadian rhythms in rheumatology - a glucocorticoid perspective
Spies, C. M., Straub, R. H., Cutolo, M., & Buttgereit, F. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4687 · Cited by 72
Self-citationSympathetic Neurotransmitters in Joint Inflammation
Straub, R. H., & Härle, P. (2005) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.09.003 · Cited by 72
Self-citationCutolo, M., Sulli, A., Pizzorni, C., Secchi, M. E., Soldano, S., SERIOLO, B., Straub, R. H., Otsa, K., & Maestroni, G. J. M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1351.027 · Cited by 73
Self-citationThe value of blocking IL-6 outside of rheumatoid arthritis: current perspective
Murakami, M., & Nishimoto, N. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283456797 · Cited by 82
Disrupted brain–immune system–joint communication during experimental arthritis
del Rey, A., Wolff, C., Wildmann, J., Randolf, A., Hahnel, A., Besedovsky, H. O., & Straub, R. H. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23869 · Cited by 68
Self-citationMorning symptoms in rheumatoid arthritis: a defining characteristic and marker of active disease
Sierakowski, S., & Cutolo, M. (2011) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2011.566433 · Cited by 67
Interplay of Environmental, Individual and Genetic Factors in Rheumatoid Arthritis Provocation
Arleevskaya, M. I., Takha, E., Petrov, S. V., Kazarian, G. G., Renaudineau, Y., Brooks, W. H., Larionova, R., Korovina, M. O., Рафкатовна, В. А., Shuralev, E. A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158140 · Cited by 66
Jamilloux, Y., Liozon, E., Pugnet, G., Nadalon, S., Heang Ly, K., Dumonteil, S., Gondran, G., Fauchais, A.-L., & Vidal, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068713 · Cited by 59
Straub, R. H., Pongratz, G., Schölmerich, J., Kees, F., Schaible, T. F., Antoni, C., Kalden, J. R., & Lorenz, H. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11036 · Cited by 57
Self-citationGeenen, R., van Middendorp, H., & Bijlsma, J. W. J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1351.007 · Cited by 56
Straub, R. H., Weidler, C., Demmel, B., Herrmann, M., Kees, F., Schmidt, M., Schölmerich, J., & Schedel, J. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.014274 · Cited by 55
Self-citationFifty Years of Experience with Cortisone Therapy in the Study and Treatment of Rheumatoid Arthritis
Neeck, G. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04199.x · Cited by 53
Straub, R. H., Schuld, A., Mullington, J. M., Haack, M., Schölmerich, J., & Pollmächer, T. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750467 · Cited by 53
Self-citationA defect in cortisol production in rheumatoid arthritis: why are we still looking?
Jessop, D. S., & Harbuz, M. S. (2005) · Rheumatology · doi:10.1093/rheumatology/keh644 · Cited by 49
Nocturnal Hormones and Clinical Rhythms in Rheumatoid Arthritis
Cutolo, M., Otsa, K., Aakre, O., & Sulli, A. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1361.079 · Cited by 47
Pool, A. J. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keg425 · Cited by 45
Imrich, R., Rovenský, J., Mális, F., Žlnay, M., Killinger, Z., Květňanský, R., Hučková, M., Vigas, M., Macho, L., & Koška, J. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.019844 · Cited by 44
Autoimmune diseases and their relation with immunological, neurological and endocrinological axes
Coronel-Restrepo, N., Posso‐Osorio, I., Naranjo-Escobar, J., & Tobón, G. J. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.05.002 · Cited by 43
Trombetta, A. C., Meroni, M., & Cutolo, M. (2017) · Frontiers of hormone research · doi:10.1159/000452911 · Cited by 40
Straub, R. H., Pongratz, G., Cutolo, M., Wijbrandts, C. A., Baeten, D., Fleck, M., Atzeni, F., Grünke, M., Kalden, J. R., Schölmerich, J., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23385 · Cited by 39
Self-citationCiurtin, C., Majeed, Y., Naylor, J., Sukumar, P., English, A., Emery, P., & Beech, D. J. (2010) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-11-111 · Cited by 38
Laboratory changes on anti-tumor necrosis factor treatment in rheumatoid arthritis
Ziółkowska, M., & Maśliński, W. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200305000-00014 · Cited by 37
Treatment of reactive arthritis with biological agents: a review
Zeng, H., Luo, B., Zhang, Y., Xie, Z., & Ye, Z. (2020) · Bioscience Reports · doi:10.1042/bsr20191927 · Cited by 38
Pituitary function in patients with newly diagnosed untreated systemic lupus erythematosus
Köller, M. D., Templ, E., Riedl, M., Clodi, M., Wagner, O., Smolen, J. S., & Luger, A. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.018325 · Cited by 38
Immunotherapeutic Implication of IL-6 Blockade
Tanaka, T., & Kishimoto, T. (2011) · Immunotherapy · doi:10.2217/imt.11.147 · Cited by 39
Pitaksalee, R., Burska, A., Ajaib, S., Rogers, J. H., Parmar, R., Mydlova, K., Xie, X., Droop, A., Nijjar, J. S., Chambers, P. A., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00837-1 · Cited by 36
Endogenous glucocorticoids in inflammation: contributions of systemic and local responses
Hardy, R., Raza, K., & Cooper, M. S. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13650 · Cited by 37
Raza, K., Hardy, R., & Cooper, M. S. (2010) · Rheumatology · doi:10.1093/rheumatology/keq212 · Cited by 31
Harbuz, M., Korendowych, E., Jessop, D., Crown, A. L., pdfan, S. L., & Kirwan (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780055 · Cited by 31
González, F. B., Villar, S. R., D’Attilio, L., Leiva, R., Márquez, J., Lioi, S., Beloscar, J., Bottasso, O. A., & Pérez, A. R. (2018) · NeuroImmunoModulation · doi:10.1159/000491699 · Cited by 31
Large Scale Metabolic Profiling identifies Novel Steroids linked to Rheumatoid Arthritis
Yousri, N. A., Bayoumy, K., Haq, W. G. E., Mohney, R. P., Emadi, S. A., Hammoudeh, S., Halabi, H. M., Masri, B. K., Badsha, H., Uthman, I. W., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05439-1 · Cited by 30
Lowin, T., Straub, R. H., Neumann, E., Bosserhoff, A., Vogel, C., Moissl‐Eichinger, C., Anders, S., Müller‐Ladner, U., & Schedel, J. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24985 · Cited by 29
Self-citationClarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. (2011) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.11.12 · Cited by 28
Self-citationStraub, R. H., Pongratz, G., Hirvonen, H., Pohjolainen, T., Mikkelsson, M., & Leirisalo‐Repo, M. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.089458 · Cited by 28
Self-citationDíaz, A., Bongiovanni, B., D’Attilio, L., Santucci, N. E., Dídoli, G., Fernández, R. D. V., Kovalevski, L., Lioi, S., Gardeñez, W., Brandan, N., et al. (2017) · Pathogens and Disease · doi:10.1093/femspd/ftx087 · Cited by 27
The Story Behind the Use of Glucocorticoids in the Treatment of Rheumatoid Arthritis
Conn, D. L. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.09.016 · Cited by 26
Straub, R. H., Detert, J., Dziurla, R., Fietze, I., Loeschmann, P.-A., Burmester, G. R., & Buttgereit, F. (2017) · NeuroImmunoModulation · doi:10.1159/000475714 · Cited by 25
Self-citationBrief ReviewEffects of Stress on Inflammatory Autoimmune Disease: Destructive or Protective?
Jessop, D. S., Richards, L. J., & Harbuz, M. S. (2004) · Stress · doi:10.1080/10253890400025497 · Cited by 26
Rao, R., DuBois, D., Almon, R. R., Jusko, W. J., & Androulakis, I. P. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00006.2016 · Cited by 25
Dudka, I., Chachaj, A., Sebastian, A., Tański, W., Stenlund, H. C., Gröbner, G., & Szuba, A. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.113971 · Cited by 25
Rheumatoid Arthritis: Neuroendocrine Immune Integrated Physiopathogenetic Perspectives and Therapy
Masi, A. T., Aldag, J. C., & Jacobs, J. W. G. (2005) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.09.006 · Cited by 25
Pierre, K. K., Rao, R., Hartmanshenn, C., & Androulakis, I. P. (2018) · Endocrinology · doi:10.1210/en.2017-03226 · Cited by 25
Demir, H., Tanrıverdi, F., Özoğul, N., Çalış, M., Kırnap, M., Durak, A. C., & Keleştimur, F. (2006) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740500474586 · Cited by 25
Liu, S., Han, L.-S., Guo, J.-Y., Zheng, Z., Li, H., Zhang, L., Zhang, X., He, Y.-J., Gao, G.-M., Liu, Z.-S., et al. (2013) · Lupus · doi:10.1177/0961203313478301 · Cited by 24
Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis
Krasselt, M., & Baerwald, C. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s87792 · Cited by 24
Tang, M. W., Koopman, F. A., Visscher, J. P. M., de Hair, M. J. H., Gerlag, D. M., & Tak, P. P. (2016) · Clinical Rheumatology · doi:10.1007/s10067-016-3456-x · Cited by 24
Rastmanesh, R., Salehi‐Abargouei, A., Shadman, Z., Ebrahimi, A. A., & Weber, C. E. (2008) · Journal of Pain · doi:10.1016/j.jpain.2008.03.006 · Cited by 24
Masi, A. T., Elmore, K. B., Rehman, A. A., Chatterton, R. T., Goertzen, N. J., & Aldag, J. C. (2013) · Autoimmune Diseases · doi:10.1155/2013/593493 · Cited by 23
Further evidence for insufficient hypothalamic-pituitary-glandular axes in polymyalgia rheumatica.
Straub, R. H., & Cutolo, M. (2006) · PubMed · Cited by 23
Self-citationCoz, G.-M. L., Fiatte, C., Anton, F., & Hanesch, U. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-35 · Cited by 22
Jacobs, J. W. G. (2012) · Lara D. Veeken · doi:10.1093/rheumatology/kes084 · Cited by 22
Chovanova, L., Vlček, M., Kršková, K., Penesová, A., Rádiková, Ž., Rovenský, J., Cholujová, D., Sedlák, J., & Imrich, R. (2014) · General Physiology and Biophysics · doi:10.4149/gpb_2013043 · Cited by 22
Clinical uses and misuses of dehydroepiandrosterone
Binello, E., & GORDON, C. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.07.006 · Cited by 22
Wei, Y., Xia, N., Zhang, W., Huang, J., Ren, Z., Zhu, L., Zhang, Z., & Yang, L. (2018) · Joint Bone Spine · doi:10.1016/j.jbspin.2018.07.002 · Cited by 21
Vaňková, M., Hill, M., Velíková, M., Včelák, J., Vacínová, G., Dvořáková, K., Lukášová, P., Vejražková, D., Rusina, R., Holmerová, I., et al. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.12.011 · Cited by 21
Llana, M. N., Sarnacki, S. H., Vázquez, M. V., Gartner, A. S., Giacomodonato, M. N., & Cerquetti, M. C. (2012) · Infection and Immunity · doi:10.1128/iai.00324-12 · Cited by 21
Targeting the time of day for glucocorticoid delivery in rheumatoid arthritis
Kirwan, J. (2011) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.11.23 · Cited by 20
Ribeiro-da-Silva, M., Vasconcelos, D. M., Alencastre, I. S., Oliveira, M. J., Linhares, D., Nevès, N., Costa, G., Henrique, R., Lamghari, M., & Alves, C. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-33360-8 · Cited by 20
Contoreggi, C. S., Rice, K. C., & Chrousos, G. P. (2004) · Neuroendocrinology · doi:10.1159/000081785 · Cited by 20
Adrenocortical dysfunction in rheumatoid arthritis: Α narrative review and future directions
Filippa, M. G., Tektonidou, M. G., Mantzou, A., Kaltsas, G., Chrousos, G. P., Sfikakis, P. P., & Yavropoulou, M. P. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13635 · Cited by 19
Hypothalamic-Pituitary-Adrenal Axis in Rheumatoid Arthritis
Imrich, R., & Rovenský, J. (2010) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2010.09.003 · Cited by 19
Wolff, C., Krinner, K., Schroeder, J. A., & Straub, R. H. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203885 · Cited by 19
Self-citationNeuroendocrine immune pathways in chronic arthritis
Capellino, S., & Straub, R. H. (2008) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2008.01.010 · Cited by 18
Self-citation
Metadata
- Authors
- Straub, R. H., Paimela, L., Peltomaa, R., Schölmerich, J., & Leirisalo‐Repo, M.
- Affiliations
- University Hospital Regensburg (DE)
- Tekonivelsairaala Orton (FI)
- Helsinki University Hospital (FI)
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2002-03
- Volume
- 46
- Issue
- 3
- Pages
- 654-662
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2006724319
- Cited by
- 183
- References
- 52
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 6 · 2020: 6 · 2019: 3 · 2018: 8 · 2017: 11 · 2016: 7 · 2015: 11 · 2014: 11 · 2013: 9 · 2012: 7
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (Str 511/5-1,2)
- Helsinki University Central Hospital Research Funds
- University Hospital Regensburg
- Orton Hospital Invalid Foundation
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- rheumatoid arthritis, reactive arthritis, interleukin-6, TNF-α, cortisol, dehydroepiandrosterone, DHEA sulfate, ACTH, adrenal steroids, 17-hydroxyprogesterone, androstenedione, joint swelling, grip strength, untreated patients, early arthritis, adrenal insufficiency
- MeSH terms
- Prohibitins, Adrenal Cortex Hormones, Adult, Aged, Aged, 80 and over, Arthritis, Rheumatoid, Female, Hormones, Humans, Male, Middle Aged, Reference Values, Retrospective Studies, Tumor Necrosis Factor-alpha, Interleukin-6, Cytokines, Arthritis, Reactive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review